← Back to Search

Minnesota RETAIN Program for Occupational Injury or Illness

N/A
Recruiting
Led By Jill Berk, PhD
Research Sponsored by Mathematica Policy Research, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be 18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured in the 12 months after enrollment
Awards & highlights

Study Summary

This trial will evaluate a program to help employees in MN who are injured or ill to stay at work and return to work.

Who is the study for?
This trial is for Minnesota residents who are at least 18 years old, have been unable to work due to injury or illness for no more than 6 months, and are currently in the labor force. Ideal candidates should not be involved in legal action related to their condition, lack a return-to-work program through their employer, or have a QRC or DCM via worker's compensation.Check my eligibility
What is being tested?
The study tests the RETAIN program's effectiveness in helping Minnesotans stay at work or return quickly after an occupational injury/illness. It involves collaboration among partners using best practices for early intervention and will randomly assign participants to either receive these services or not.See study design
What are the potential side effects?
Since this trial focuses on workplace interventions rather than medical treatments, it does not involve typical medication side effects. However, there may be indirect effects related to changes in workplace routines or stress levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured in the 12 months after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured in the 12 months after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Enrollee earnings in the fourth quarter after enrollment
Share of enrollees employed in the fourth quarter after enrollment
Share of enrollees that applied for SSDI or SSI during the 12 months after enrollment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: RETAIN ProgrammingExperimental Treatment1 Intervention
The experimental group receives the full set of RETAIN intervention activities.
Group II: ControlActive Control1 Intervention
The control group does not receive the full set of RETAIN intervention activities.

Find a Location

Who is running the clinical trial?

Mathematica Policy Research, Inc.Lead Sponsor
57 Previous Clinical Trials
6,115,293 Total Patients Enrolled
Social Security AdministrationUNKNOWN
2 Previous Clinical Trials
5,240 Total Patients Enrolled
Department of Labor and IndustryUNKNOWN

Media Library

Minnesota RETAIN Clinical Trial Eligibility Overview. Trial Name: NCT05146349 — N/A
Occupational Injury or Illness Research Study Groups: RETAIN Programming, Control
Occupational Injury or Illness Clinical Trial 2023: Minnesota RETAIN Highlights & Side Effects. Trial Name: NCT05146349 — N/A
Minnesota RETAIN 2023 Treatment Timeline for Medical Study. Trial Name: NCT05146349 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available enrollments in this research initiative?

"As indicated on clinicaltrials.gov, this trial is still in the process of recruitment. The posting was made public on December 23rd 2021 and last modified on January 7th 2022."

Answered by AI

What is the scale of participation in this trial?

"Indeed, the records listed on clinicaltrials.gov attest that this trial is currently seeking to enroll patients. The study was first published on December 23rd 2021 and has recently been updated in January 7th 2022. 3200 people must be recruited from 1 site for it to commence."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Minnesota RETAIN Impact Evaluation
2021. "Minnesota RETAIN Impact Evaluation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05146349.
~1015 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top